This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIRx Med, is properly cited. The complete bibliographic information, a link to the original publication on https://med.jmirx.org/, as well as this copyright and license information must be included.
This is a peer-review report submitted for the paper “The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study.”
Round 1 Review
The manuscript [1] attempts to investigate the impact of SARS-CoV-2 lineages in South African COVID-19 epidemiology. I would like to congratulate the authors on this useful attempt. The manuscript is well written, and the subject addressed in this manuscript is worth investigating; however, the manuscript partly failed to present a clear picture of its analytical methodology and presentation of results. The following are some minor concerns for consideration. I suggest that the authors (a) extend the study to include the recent Omicron variant, (b) present results with complete models, (c) avoid excessive references (~71).
In conclusion, the subject addressed in this manuscript is worth investigating and acceptable after taking into account the abovementioned minor issues.
None declared.
MabukaTNaidooNNcubeNYigaTRossMKurehwaKNareMSilajiANdemeraTLemekeTTaiwoRMachariaWSitholeMThe impact of SARS-CoV-2 lineages (variants) and COVID-19 vaccination on the COVID-19 epidemic in South Africa: regression studyJMIRx Med20234e34598